ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 1924

Racial and Gender Disparities in Psoriatic Arthritis Clinical Trials

Dania Kaur1, Fizza Zulfiqar2, Akshee Batra3 and Abhinav Vyas4, 1North Alabama Medical Center, Muscle Shoals, AL, 2Trinity Health Oakland/Wayne State University, Pontiac, MI, 3University of Miami, Miami, FL, 4Vanderbilt University Medical Center, Nahville, TN

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: gender, Psoriatic arthritis, race/ethnicity

Session Information

Date: Monday, November 18, 2024

Title: Healthcare Disparities in Rheumatology Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: To develop effective novel treatment strategies for psoriatic arthritis that cater to patients from diverse backgrounds, it is crucial that all racial groups, without exception, have equal opportunities to participate in clinical trials.

Methods: Using ClinicalTrials.gov, a web-based resource that registers all studies meeting the definition of a clinical trial according to the International Committee on Medical Journal Editors, we identified all phase 1 to phase 4 psoriatic arthritis clinical trials. We manually abstracted data on the racial distribution of enrolled participants, sex distribution, trial phase, location, and year of trial reporting. Additionally, we conducted subgroup analyses of racial distribution based on trial phase and location and evaluated trends in racial disparity within clinical trial enrollment over the years.

Results: We identified 84 clinical trials related to Psoriatic arthritis, of which 91.6% were done in Europe or the United States. Most of these were phase 3 clinical trials (60.7%). The racial distribution of enrolled participants was publicly available in 51(60.7%)  clinical trials. The race distribution of enrolled subjects was reported in 50% of Phase 1, 70.6% in Phase 2, 60.9% in Phase 3 and 60% in Phase 4. The race distribution among 15266 study participants in 51 clinical trials was: 85.1% Whites (12997), 1.25 % Blacks (182), 9.2% Asians (1399), 2% other races (306), and 1.6% (246) subjects with unreported race. The same race distribution trend was observed across all subgroups of clinical trials based on phase. The sex distribution, as seen throughout the trials, was 51.9% in males(13998) and 48.1% in females(12959).

Conclusion: Our research has shown that only 60.7% of psoriatic arthritis studies had racial distribution published. We noted a decreased representation of blacks, whereas a higher representation of Asians. Strategies to implement equitable representation in clinical trials in psoriatic arthritis are needed.


Disclosures: D. Kaur: None; F. Zulfiqar: None; A. Batra: None; A. Vyas: None.

To cite this abstract in AMA style:

Kaur D, Zulfiqar F, Batra A, Vyas A. Racial and Gender Disparities in Psoriatic Arthritis Clinical Trials [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/racial-and-gender-disparities-in-psoriatic-arthritis-clinical-trials/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-and-gender-disparities-in-psoriatic-arthritis-clinical-trials/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology